0000049071-18-000043.txt : 20180227
0000049071-18-000043.hdr.sgml : 20180227
20180227183817
ACCESSION NUMBER: 0000049071-18-000043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180224
FILED AS OF DATE: 20180227
DATE AS OF CHANGE: 20180227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Christopher M Todoroff
CENTRAL INDEX KEY: 0001441437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-05975
FILM NUMBER: 18647226
MAIL ADDRESS:
STREET 1: HUMANA INC.
STREET 2: 500 WEST MAIN STREET
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMANA INC
CENTRAL INDEX KEY: 0000049071
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 610647538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 W MAIN ST
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
BUSINESS PHONE: 5025801000
MAIL ADDRESS:
STREET 1: 500 W. MAIN ST
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
FORMER COMPANY:
FORMER CONFORMED NAME: EXTENDICARE INC
DATE OF NAME CHANGE: 19740404
FORMER COMPANY:
FORMER CONFORMED NAME: HERITAGE HOUSE OF AMERICA INC
DATE OF NAME CHANGE: 19671129
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2018-02-24
0000049071
HUMANA INC
HUM
0001441437
Christopher M Todoroff
HUMANA INC.
500 WEST MAIN STREET
LOUISVILLE
KY
40202
0
1
0
0
Chief Legal Officer
Humana Common
2018-02-24
4
M
0
4472
0
A
13447
D
Humana Common
2018-02-24
4
F
0
1575
269.31
D
11872
D
Humana Common
2018-02-27
4
M
0
7005
164.645
A
18877
D
Humana Common
2018-02-27
4
M
0
6935
167.805
A
25812
D
Humana Common
2018-02-27
4
S
0
16389
273.3724
D
9423
D
Options
164.645
2018-02-27
4
M
0
7005
0
D
2022-02-24
Humana Common
7005
0
D
Options
167.805
2018-02-27
4
M
0
6935
0
D
2023-02-18
Humana Common
6935
6935
D
Options
217.415
2024-03-08
Humana Common
15498
15498
D
Options
239.12
2024-06-28
Humana Common
7366
7366
D
Options
268.47
2025-02-19
Humana Common
6221
6221
D
Restricted Stock Units
Humana Common
1540
1540
D
Restricted Stock Units
Humana Common
2377
2377
D
Restricted Stock Units
Humana Common
1620
1620
D
Restricted Stock Units
Humana Common
1443
1443
D
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/15, vesting in three increments from 02/24/16 to 02/24/18.
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/18/16, vesting in three increments from 02/18/17 to 02/18/19.
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 03/08/2017, vesting in three annual increments.
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 06/28/2017, 100% of the award is vesting on 06/28/20
Right to buy pursuant to Company's 2011 Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/19/18, vesting in three increments from 02/19/19 to 02/19/21.
Right to receive one share per restricted stock unit pursuant to the Company's 2011 Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).
Restricted stock units granted to reporting person on 02/18/16, 33% of the award is vesting on 12/15/16, 12/15/17, and 12/15/18.
Reporting Person disclaims Beneficial Ownership of one-half of each option or restricted stock unit held as of December 2016 pursuant to Divorce Decree, exempt under Rule 16a-12.
Restricted stock units granted to reporting person on 03/08/2017, 33% of the award is vesting on 12/15/17, 12/15/18, and 12/15/19.
Restricted stock units granted to reporting person on 06/28/17, 100% of the award is vesting on 06/28/20.
Restricted stock units granted to reporting person on 02/19/18, 33% of the award is vesting on 12/15/18, 12/15/19, and 12/15/20.
Includes Performance Stock Units that vested on 2/24/2018.
Shares sold from prices ranging from $273.10422 to $275.75. Price reported is weighted avg sales price.
Christopher M. Todoroff
2018-02-27